111° West Capital

San Francisco, California
Founded:2021
Firm Location:San Francisco, California • Santa Monica, California
Investor Firms That Co-Invest with 111° West Capital
111° West Capital Team
Photo of Andrew Brooks, Managing Partner at 111° West Capital
Andrew Brooks
111° West Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Santa Monica (CA)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Analytics (Seed), Investors in BioTech (Seed), Investors in Analytics (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Analytics (Pre-seed), Investors in AI (Pre-seed), Investors in Analytics (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in AI (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health & Hospital Services (Seed)
Photo of Michael Matly, Managing Partner at 111° West Capital
Michael Matly
111° West Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Analytics (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Analytics (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Analytics (Pre-seed), Investors in Health IT (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Analytics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Health IT (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in AI (Seed), Investors in Health & Hospital Services (Seed)
Photo of Dan Tully, Principal at 111° West Capital
Dan Tully
Sweet spot: $10.0M
Range: $5.0M - $25.0M
Investors in AI (Series B), Investors in Payments (Series B), Investors in Payments (Series A), Investors in FinTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in SaaS (Series B), Investors in AI (Series A), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Cybersecurity (Series B), Investors in Cybersecurity (Series A), Investors in Digital Health (Series B), Investors in SaaS (Series A), Investors in FinTech (Series A), Investors in Health IT (Series B), Investors in Digital Health (Series A)